|
Report Date : |
15.05.2013 |
IDENTIFICATION DETAILS
|
Name : |
LIPTIS EGYPT FOR PHARMACEUTICAL PRODUCTS CO |
|
|
|
|
Formerly Known As : |
LIPTIS EGYPT CO / LIPTIS PHARMACEUTICALS |
|
|
|
|
Registered Office : |
65 Manial Street, El Pasha Square, Manial, Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Date of Incorporation : |
2004 |
|
|
|
|
Com. Reg. No.: |
48828 |
|
|
|
|
Legal Form : |
Limited Liability Partnership |
|
|
|
|
Line of Business : |
Manufacturers of pharmaceutical preparations. |
|
|
|
|
No. of Employees : |
250 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March, 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Egypt |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EGYPT - ECONOMIC OVERVIEW
Occupying the northeast corner of the African continent,
Egypt is bisected by the highly fertile Nile valley, where most economic activity
takes place. Egypt's economy was highly centralized during the rule of former
President Gamal Abdel NASSER but opened up considerably under former Presidents
Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 aggressively
pursued economic reforms to attract foreign investment and facilitate GDP
growth. Despite the relatively high levels of economic growth in recent years,
living conditions for the average Egyptian remained poor and contributed to
public discontent. After unrest erupted in January 2011, the Egyptian
Government backtracked on economic reforms, drastically increasing social
spending to address public dissatisfaction, but political uncertainty at the
same time caused economic growth to slow significantly, reducing the government's
revenues. Tourism, manufacturing, and construction were among the hardest hit
sectors of the Egyptian economy, and economic growth is likely to remain slow
during the next several years. The government drew down foreign exchange
reserves by more than 50% in 2011 and 2012 to support the Egyptian pound and
the dearth of foreign financial assistance - as a result of unsuccessful
negotiations with the International Monetary Fund over a multi-billion dollar
loan agreement which have dragged on more than 20 months - could precipitate
fiscal and balance of payments crises in 2013.
|
Source
: CIA |
Company Name :
LIPTIS EGYPT FOR
PHARMACEUTICAL PRODUCTS CO
Also Known As : LIPTIS EGYPT CO / LIPTIS PHARMACEUTICALS
Country of Origin :
Egypt
Legal Form :
Limited Liability Partnership
Registration Date :
2004
Commercial Registration Number :
48828
Tax Card Number :
431-157-022
Issued Capital :
£E 10,000,000
Paid up Capital :
£E 10,000,000
Total Workforce :
250
Activities :
Manufacturers of pharmaceutical preparations.
Financial Condition :
Undetermined
Payments :
Nothing detrimental uncovered
LIPTIS EGYPT FOR PHARMACEUTICAL PRODUCTS CO
LIPTIS EGYPT CO / LIPTIS PHARMACEUTICALS
Registered &
Physical Address
Street : 65 Manial
Street
Area : El Pasha
Square, Manial
Town : Cairo
Country : Egypt
Telephone : (20-2) 25310174
Facsimile : (20-2)
23687847 / 23683423
Premises
Subject operates from a large suite of offices that are rented and
located in the Suburban Business Area of Cairo.
Branch Office (s)
Location Description
6th Industrial Zone, Area B2 Factory
premises
6th of October City
Tel: (20-10) 3333992
Name Position
Dr Lotfy Ismail Omar Managing
Partner
Dr Ahmed Samir General
Manager
Nasr Hassan Finance
Manager
Mohamed Alaa Administration
Manager
Mohamed Nabil Purchasing
Manager
Ali Fathy Sales
Manager
Date of Establishment : 2004
Legal Form : Limited Liability
Partnership
Commercial Reg. No. : 48828
Tax Card No. : 431-157-022
Issued Capital : £E 10,000,000
Paid up Capital : £E 10,000,000
Name of Shareholder
(s)
Dr Lotfy Ismail Omar
Members of Dr Lotfy Ismail Omar’s family
Activities: Engaged in the manufacture
of pharmaceutical preparations. Subject is currently in the process of
launching a new production line for baby milk under licence of Hok Dorf
(Switzerland).
Import Countries: Switzerland
and Egypt.
Subject has a workforce of approximately 250 employees.
Companies registered in Egypt are not legally required to make their accounts
public and no financial information was released by the company or submitted by
outside sources.
Export Development Bank of Egypt
108 Mohi El Din Abu El Ezz Street
Mohandessin
Cairo 11111
Tel: (20-2) 33619005 / 33385877
Fax: (20-2) 33385940 / 33385938
No complaints regarding subject’s payments have been reported.
During the course of this investigation nothing detrimental was
uncovered regarding subject’s operating history or the manner in which payments
are fulfilled. As such the company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.63 |
|
|
1 |
Rs.83.67 |
|
Euro |
1 |
Rs.71.02 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.